A study commissioned by President Joe Biden's administration to investigate alcohol-related health harms was released independently on Tuesday, after President Donald Trump's administration decided ...
Standard Versus Reduced Sotorasib Dosing in KRAS G12C–Mutated Non–Small Cell Lung Cancer: A Systematic Review and Meta-Analysis—Have We Answered the Dosing Question? Excess weight is a key modifiable ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lung cancer is among the conditions that may be affected. GLP-1 medications such as Wegovy, ...
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Limited time: ...
You can have up to 10 Bob-ombs on hand at a time. The distance Bob-ombs can be thrown depends on how long you hold the L Button. Adjusted the performance of Bullet Bill. Increased their range of ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1s are ...
The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints — stomachaches, constipation — generally unpleasant but tolerable ...
A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...
A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...
GLP-1 drugs reduced substance use disorders in patients with type 2 diabetes. GLP-1 users had lower odds of new disorders or adverse outcomes of existing disorders. Effect was seen across broad range ...
A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results